| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |